top of page

BioVenture VoiCes Episode 5: KdT Ventures' Founder and Managing Partner Cain McClary

  • blonca9
  • Nov 4, 2024
  • 1 min read

He describes this path to venture investing from his start in science at the NIH to becoming a pathologist, and eventually raising a modest first fund and building off of its success. Plus, his investment philosophy and investing in science - including outside of therapeutics.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen_Logo_RGB.png

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page